Effect of metabolic syndrome on cardiovascular, hepatic events, and death in chronic hepatitis B patients: Methodological issues
Erfan Ayubi, Saeid Safiri, Mohadeseh Sani, Amin Doosti‐Irani, Ali Sanjari Moghaddam – 23 December 2016
Reply
Jenny Yeuk‐Ki Cheng, Yee‐Kit Tse, Grace Lai‐Hung Wong – 23 December 2016
Sofosbuvir/ledipasvir and ribavirin tolerability and efficacy in pediatric liver transplant recipients
Koen Huysentruyt, Xavier Stephenne, Sharat Varma, Isabelle Scheers, Gisèle Leclercq, Françoise Smets, Etienne M. Sokal – 22 December 2016
Impact of emergency adult living donor liver transplantation on the survival of patients with antituberculosis therapy‐induced acute liver failure
Jin‐Young Huh, Danbi Lee, Jihyun Ahn, Ju Hyun Shim, Young‐Suk Lim, Gil‐Chun Park, Gi‐Won Song, Ki‐Hun Kim, Dong‐Hwan Jung, Deok‐Bog Moon, Shin Hwang, Sung Gyu Lee, Sei Won Lee, Jin‐Woo Song, Yeon‐Mok Oh, Tae Sun Shim, Kyung‐Wook Jo – 22 December 2016
Neutrophil‐to‐lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end‐stage liver disease patients with cirrhosis
Avash Kalra, Joel P. Wedd, Kiran M. Bambha, Jane Gralla, Lucy Golden‐Mason, Christine Collins, Hugo R. Rosen, Scott W. Biggins – 22 December 2016 – The Model for End‐Stage Liver Disease (MELD) score has reduced accuracy for liver transplantation (LT) wait‐list mortality when MELD ≤ 20. Neutrophil‐to‐lymphocyte ratio (NLR) is a biomarker associated with systemic inflammation and may predict cirrhotic decompensation and death. We aimed to evaluate the prognostic utility of high NLR (≥4) for liver‐related death among low MELD patients listed for LT, controlling for stage of cirrhosis.
Transplant‐related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinoma
George N. Ioannou – 22 December 2016 – Transplant‐related survival benefit is calculated as the difference between life expectancy with transplantation and life expectancy without transplantation.
Management of biliary anastomotic strictures after liver transplantation (BASALT study): A nationwide Italian survey
Paolo Cantù, Ilaria Parzanese, Valerio Balassone, Antonio Sario, Fiammetta Soggiu, Giovanni Lombardi, Federico Barbaro, Antonio Pisani, Anna Baldan, Giulio Cariani, Valentina Boarino, Alberto Fasoli, Helga Bertani, Edoardo Forti, Milutin Bulajic, Davide Ghinolfi, Elena Nadal, Angelo Cerofolini, Luca Barresi, Giorgia Catalano, Italo Stroppa, Sara Traini, Vincenzo Mazzaferro, Livio Cipolletta, Andrea Tringali, Guido Costamagna, Paolo Ravelli, Franco Bazzoli, Alberto Merighi, Maria Caterina Parodi, Rita Conigliaro, Massimiliano Mutignani, Maurizio Zilli, Franco Filipponi, Alberto Fantin, Luca
Budd‐chiari syndrome and acute liver failure: A complex condition requiring a rapid response
John G. O'Grady – 22 December 2016
Living liver donation, donor safety, and social media: Preparing for a new frontier
Talia B. Baker – 22 December 2016
Can response to locoregional therapy help predict longterm survival after liver transplantation for hepatocellular carcinoma? A systematic review
Paul D. Morris, Jerome M. Laurence, David Yeo, Michael Crawford, Simone I. Strasser, Geoffrey W. McCaughan, Charbel Sandroussi – 22 December 2016 – For a selected group of patients with hepatocellular carcinoma (HCC), liver transplantation (LT) represents the best chance of a cure. Organ shortages necessitate an efficient allocation of resources and careful prioritization on the transplantation waiting list.